ClearPoint Neuro, founded in Irvine, United States, is dedicated to enhancing the quality of life for patients and their families by providing precise therapies for complex neurological disorders. The company specializes in offering comprehensive neurosurgical solutions that combine real-time direct imaging with advanced hardware and software, enabling neurosurgeons to make intraprocedural adjustments. ClearPoint Neuro focuses on global device, cell, and gene therapy, providing precise navigation for brain and spine procedures.
Notable affiliated individuals and investors include key figures in the medical and biotech industries, although specific names are not provided. ClearPoint Neuro has achieved significant milestones in neurosurgery, partnering with leading neurosurgery centers and biologics and drug delivery companies. The company's impact is evident in its contribution to advancing neurosurgical precision and improving patient outcomes globally.
